Ligand validation:3CL5

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3CL5 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CL5_NAG_A_2521	67%	65%	0.123	0.932	0.45	0.88	-	-	0	0	100%	1
3CL5_NAG_A_2523	63%	58%	0.125	0.921	0.62	1	-	2	0	0	100%	1
3CL5_NAG_A_2527	18%	53%	0.244	0.831	0.6	1.21	-	1	7	0	100%	1
3CL5_NAG_A_1961	18%	55%	0.296	0.882	0.55	1.16	-	1	0	0	100%	1
3CL5_NAG_A_2520	9%	54%	0.306	0.794	0.64	1.13	-	2	0	0	100%	1
3CL4_NAG_A_2523	85%	34%	0.101	0.967	1.15	1.43	1	2	0	0	100%	1
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	1
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	1
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	1
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	1
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.